Cited by 430Mesenchymal stem cell researchTGF-β signaling in diseasesSystemic Sclerosis and Related Diseases

Mesenchymal stem cells in fibrotic disease

Open access
El Agha, Elie, Kramann, Rafael, Schneider, Rebekka K., Li, Xiaokun, Seeger, Werner, Humphreys, Benjamin D., Bellusci, Saverio·2017·Cell stem cell

Abstract

Fibrosis is associated with organ failure and high mortality and is commonly characterized by aberrant myofibroblast accumulation. Investigating the cellular origin of myofibroblasts in various diseases is thus a promising strategy for developing targeted anti-fibrotic treatments. Recent studies using genetic lineage tracing technology have implicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-MSCs in myofibroblast generation during fibrosis development. In this Review, we give an overview of the emerging role of MSCs and MSC-like cells in myofibroblast-mediated fibrotic disease in the kidney, lung, heart, liver, skin, and bone marrow.

Integrity signals

Registry

Crossref · 10.1016/j.stem.2017.07.011

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BM mesenchymal stromal cells (BM-MSCs) are a rare population of cells in proximity to arterioles and sinusoid vessels (perivascular niche) or in proximity to the bone (endosteal niche).

    “BM mesenchymal stromal cells (BM-MSCs) are a rare population of cells in proximity to arterioles and sinusoid vessels (perivascular niche) or in proximity to the bone (endosteal niche).6”

    From Inflammatory bone marrow microenvironment (2019) · cites this paper as [6]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
El Agha, E., Kramann, R., Schneider, R. K., Li, X., Seeger, W., Humphreys, B. D., & Bellusci, S.
Affiliations
  • RWTH Aachen University (DE)
  • Erasmus MC Cancer Institute (NL)
  • Wenzhou University (CN)
  • Justus-Liebig-Universität Gießen (DE)
  • Washington University in St. Louis (US)
Venue
Cell stem cell
Publisher
Elsevier BV
Published
2017-08
Volume
21
Issue
2
Pages
166-177
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2743476964
Cited by
430
References
99
Citations by year
2026: 15 · 2025: 32 · 2024: 54 · 2023: 44 · 2022: 78 · 2021: 66 · 2020: 70 · 2019: 42 · 2018: 26 · 2017: 1 · 2014: 1 · 2012: 1
FWCI
5.37
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • Excellence Cluster Cardio-Pulmonary System (ECCPS)
  • Universitätsklinikum Gießen und Marburg (UKGM)
  • German Center for Lung Research (DZL)
  • German Research Foundation
  • DFG (BE4443/4-1, BE4443/6-1, KFO 309, CRC1213, SCHN 1188/5-1, KR-4073/3-1, SFBTRR57)
  • Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE)
  • UKGM
  • Universities of Giessen and Marburg Lung Center (UGMLC)
  • DZL
  • COST (BM1201)
  • NIH/NHLBI (1R01HL086322-01A2, HL107307)
  • Interdisciplinary Center for Clinical Research (IZKF) RWTH Aachen (O1-5)
  • European Hematology Association (EHA)
  • European Research Council (ERC-StG 677448)
  • RWTH Aachen University (101/15)
  • Return to NRW)
  • NIH/NIDDK (DK088923, DK103740, DK103050)
  • American Heart Association (EIA14650059)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
Keywords
mesenchymal stem cells, fibrosis, myofibroblast accumulation, perivascular stem cells, bone marrow-derived mesenchymal stem cells, lineage tracing, renal fibrosis, pulmonary fibrosis, myocardial fibrosis, liver fibrosis, skin fibrosis, bone marrow fibrosis, antifibrotic therapy
MeSH terms
Animals, Fibrosis, Humans, Organ Specificity, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review